In order to further validate this finding, we used subcutaneous and orthotopic implantation mouse models to perform gain- and loss-of-function analyses and provide evidence to support that GOLM1 promotes the expression of PD-L1 both on HCC cells and TAMs, and induces T cell suppression in HCC. This evidence concerns the gene CD274 and hepatocellular carcinoma.